Skip to main content
SpringerLink
Log in
Book cover

Cardiac Glycosides 1785–1985

Biochemistry — Pharmacology — Clinical Relevance

  • Conference proceedings
  • © 1986

Overview

Editors:
  1. Erland Erdmann

    1. Medizinische Klinik I, Klinikum Großhadern der Universität München, München 70, West Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. K. Greef

    1. Institut für Pharmakologie, Universität Düsseldorf, Düsseldorf, West Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. J. C. Skou

    1. Biophysik Institut, Aarhus Universitet, Aarhus, Denmark

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (72 papers)

  1. Front Matter

    Pages I-XVII
    Download chapter PDF

  3. Cardiac glycosides, (Na+ + K+)-ATPase and cation transport

    1. The function of Na+,K+-ATPase and its importance for drug action

      • T. Akera
      Pages 19-25

    2. Structural studies on the cardiac glycoside receptor

      • E. T. Wallick, T. L. Kirley, A. Schwartz
      Pages 27-33

    3. Isoenzymes of Na,K-ATPase identified by pyrithiamin

      • Otto Hansen
      Pages 35-40

    4. Interaction of cardiac glycosides with Na/K-ATPase in intact myocardium

      • S. Herzig, H. Lüllmann, K. Mohr
      Pages 41-47

    5. The human red blood cell: A model for ouabain receptor regulation in the heart?

      • Lindsay Brown, K. Werdan, E. Erdmann
      Pages 49-54

    6. Binding and release of ouabain at low Mg2+ in reconstituted human red blood cell ghosts

      • H. H. Bodemann
      Pages 55-59

    7. The ouabain receptor in the myocardium and conduction system of the sheep heart

      • E. Hug, L. Brown, Erland Erdmann
      Pages 61-68

    8. Electrophysiological effects of cardiac glycosides

      • D. A. Eisner, M. Valdeolmillos, W. J. Lederer, M. B. Cannell
      Pages 69-78

    9. Electrophysiological assay of glycoside-induced sodium pump inhibition in isolated sheep heart Purkinje fibres at the onset of toxicity

      • C. Achenbach, Han Daying, R. Preisler
      Pages 79-86

    10. Rat cardiac hypertrophy: contribution of heteregeneous digitalis receptor forms

      • L. G. Lelièvre, J. M. Maixent, D. Charlemagne, B. Swynghedauw
      Pages 87-92

    11. Digitalis receptors in normal and hypertrophied rat hearts. Differential effects of a Ca2+ free perfusion

      • D. Charlemagne, E. Mayoux, M. Preteseille, J. M. Maixent, Ch. Mouas, B. Swynghedauw et al.
      Pages 93-98

    12. Biphasic contractile response to ouabain: Species specific? Calcium dependent? Altered sensitivity?

      • G. Grupp, Ingrid L. Grupp, T. Hickerson, S. W. Lee, A. Schwartz
      Pages 99-108

    13. The influence of α-tocopherol-nicotinate (Renascin®) on cardiac glycoside effects

      • H. Tawfik, P. Schlieper
      Pages 109-117

    14. On the connection between cardiac glycosides and calcium action

      • H. Waginger, D. S. Regal
      Pages 119-125

    15. Biochemical basis for the targeted synthesis of cardiac glycosides with selective action

      • W. Schönfeld, J. Weiland, K. R. H. Repke
      Pages 127-134

  4. Digitalis-like substances

    1. The “endogenous cardiac glycoside”

      • W. Schoner, K. Moreth, R. Kuske, D. Renner
      Pages 135-142
Back to top

Keywords

About this book

The bicentenary of William Withering's now famous medical report entitled "An Account of the Foxglove and Some of its Medical Uses" has given us the occasion to analyze the state of the art. Cardiac glycosides in 1985 are considered tobe the basis for medical treatment of myocardial failure, together with diuretics and vasodilators in the more severe cases. Nevertheless, the controversy as to their exact place in the treatment of heart failure with sinus rhythm has never ceased. Although cardiac glycosides are of unquestionable value in tachycardia caused by atrial fibrillation or atrial flutter, the chronic use of these drugs in sinus rhythm is not generally accepted. The development of tolerance has been reported. It is of interest that Withering hirnself wrote: "-let it (foxglove) be continued until it either acts on the kidneys, the stomach, the pulse, or the bowels; Iet it be stopped upon the first appearance of any of these effects, and I will maintain that the patient will not suffer from its exhibition, nor the practitioner be disappointed in any reasonable expectation. " In West Germany alone, more than three million patients (about 5% of the total population) are constantly taking cardiac glycosides. These drugs are the most prescribed medicaments in many countries. Thus, we considered it worthwhile and necessary to review in a critical way today's knowledge about the foxglove; to report new findings and to evaluate old Statements.

Editors and Affiliations

  • Medizinische Klinik I, Klinikum Großhadern der Universität München, München 70, West Germany

    Erland Erdmann

  • Institut für Pharmakologie, Universität Düsseldorf, Düsseldorf, West Germany

    K. Greef

  • Biophysik Institut, Aarhus Universitet, Aarhus, Denmark

    J. C. Skou

Bibliographic Information

  • Book Title: Cardiac Glycosides 1785–1985

  • Book Subtitle: Biochemistry — Pharmacology — Clinical Relevance

  • Editors: Erland Erdmann, K. Greef, J. C. Skou

  • DOI: https://doi.org/10.1007/978-3-662-11292-2

  • Publisher: Steinkopff Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1986

  • Softcover ISBN: 978-3-662-11294-6Published: 20 November 2013

  • eBook ISBN: 978-3-662-11292-2Published: 29 June 2013

  • Edition Number: 1

  • Number of Pages: XVII, 552

  • Additional Information: Jointly published with Springer-Verlag New York: ISBN 0-387-91275-4

  • Topics: Cardiology

Publish with us

Policies and ethics

Back to top

Search

Navigation